Rofecoxib, as a safe alternative for acetyl salicylic acid/nonsteroidal anti-inflammatory drug-intolerant patients

BAVBEK S., ÇELİK G. E., Pasaoglu G., Misirligil Z.

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, cilt.16, sa.1, ss.57-62, 2006 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 16 Sayı: 1
  • Basım Tarihi: 2006
  • Dergi Adı: JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.57-62
  • Anahtar Kelimeler: aspirin intolerance, asthma, rofecoxib, urticaria, anaphylactoid reaction, SELECTIVE CYCLOOXYGENASE-2 INHIBITOR, ASPIRIN, NIMESULIDE, TOLERABILITY, MELOXICAM, ATOPY
  • Ankara Üniversitesi Adresli: Evet

Özet

Background: Intolerance to acetylsalicylic acid (ASA) and nonsteroidal anti-inflammatory drugs (NSAIDs) is a crucial problem in medical practice. There is therefore a need for safer NSAIDs in analgesic-intolerant patients.